More consolidation in the in vitro diagnostics (IVD) market may soon happen. Bio-Rad Laboratories and Qiagen are reportedly in merger discussions. The Wall Street Journal, which broke the story on Oct. 10, tabbed the potential deal as being worth $10 billion should it go through. Both companies have a global presence and make most of …
Reports Say Qiagen and Bio-Rad Discussing Potential IVD Merger Read More »
